There are fifteen patents protecting this drug. This drug has two hundred and nineteen patent family members in forty countries. There are twenty-eight drug master file entries for this compound.
Nine suppliers are listed for this compound. Additional details are available on the fluticasone propionate; salmeterol xinafoate profile page. This preview shows a limited when will advair diskus go generic in usa set. Subscribe to access the full database, or try a Free Trial. Serving hundreds of leading biopharmaceutical when will advair diskus go generic in usa globally: Drugs may be covered by multiple patents or regulatory protections.
All trademarks and applicant names are the property of their respective owners or licensors. Although great care is more info in when will advair diskus go generic in usa proper and correct provision of this when will advair diskus go generic in usa, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information.
Visit the Subscription Options page for details on plans and pricing. Exclusivity Expiration This preview shows a limited data set. Patent Expiration This preview shows a limited data set.
Alerts are when will advair diskus go generic in usa for users with active subscriptions. I'm just browsing I want to know about pricing I would like a free trial I have another question Yes No.
By using our website you are consenting to our use of cookies in accordance with our privacy policy.
While the product was approved in February, there were quite a few hurdles that needed to be jumped before the product was ready to be introduced to the market. Apparently, those hurdles have been met, and the product is now on the market.
It contains the corticosteroid fluticasone and the long acting beta agonist salmeterol, just like Advair. The problem is that the salmeterol dose is less than that of Advair , making it less than ideal. The question of the day is, why are there not generic advairs on the market that are compatible with the brand product Advair?
LONDON Reuters - GlaxoSmithKline is likely to escape generic competition to its blockbuster lung drug Advair in the United States this year, after a second application for a cut-price equivalent form of the medicine was turned down by U. Hikma and its partner Vectura are in a race with Mylan to launch the first U. Hikma and Mylan have received so-called complete response letters from the FDA that were categorized as major.
2018 ©